Phytobiotics secures new patent for Sangrovit technology

04/06/2026

As livestock producers continue to seek alternatives that support animal performance while reducing reliance on traditional interventions, innovation in phytogenic feed additives remains a key area of focus. Against this backdrop, Phytobiotics has announced a new patent related to its Sangrovit product platform, reinforcing the company’s position in plant-based feed solutions.

The German feed additive specialist said the newly granted patent covers aspects of the latest generation of Sangrovit technology, a product line based on specific plant-derived compounds used in animal nutrition. The development reflects the company’s ongoing investment in research and intellectual property within the phytogenic feed additive segment.

Phytobiotics has marketed Sangrovit for more than two decades and positions the product as a solution designed to support feed intake, gut function and animal performance across multiple livestock species. The company noted that continued innovation is aimed at helping producers meet productivity goals while adapting to changing market and regulatory expectations.

Interest in phytogenic additives has increased globally as animal production systems place greater emphasis on efficiency, sustainability and responsible use of veterinary interventions. This trend has created growing demand for feed technologies that support animal health and performance through nutritional approaches.

By strengthening the intellectual property surrounding Sangrovit, Phytobiotics aims to further differentiate its portfolio in a competitive feed additive market that increasingly values scientifically documented solutions.

The patent announcement also highlights the broader role of innovation in the feed sector, where companies continue to invest in novel technologies designed to improve livestock productivity while supporting long-term sustainability objectives.

For further information > Phytobiotics GmbH